Koen, Joshua D.
Lewis, Leslie
Rugg, Michael D.
Clementz, Brett A.
Keshavan, Matcheri S.
Pearlson, Godfrey D.
Sweeney, John A.
Tamminga, Carol A.
Ivleva, Elena I.
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Institute on Aging (F32AG049583, R56AG068149, R01AG039103, MH078113, MH077945, MH077862, MH077851, K23MH102656, R01MH127317)
Aging Mind Foundation
Article History
Received: 9 June 2022
Accepted: 3 July 2023
First Online: 10 August 2023
Competing interests
: All authors report no non-financial competing interest with any biomedical or other associations relevant to this manuscript. Individual disclosures of biomedical financial interest are listed below: Dr. Sweeney consulted to VeraSci. Dr. Tamminga consulted to Astellas and Sunovion Pharmaceutical. She served on clinical advisory board for Kynexis and medical advisory board for Karuna. She is also a council member (unpaid) for The Brain & Behavior Research Foundation/NARSAD. Dr. Ivleva consulted to Janssen Scientific Affairs, LLC and Alkermes, Inc. The rest of the authors report no competing financial or non-financial interests.